Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2016

Open Access 01-12-2016 | Research article

Short- to long-term follow-up of total femoral replacement in non-oncologic patients

Authors: Andreas Toepfer, Norbert Harrasser, Isabel Petzschner, Florian Pohlig, Ulrich Lenze, Ludger Gerdesmeyer, Dominik Pförringer, Marcel Toepfer, Marc Beirer, Moritz Crönlein, Ruediger von Eisenhart-Rothe, Heinz Mühlhofer

Published in: BMC Musculoskeletal Disorders | Issue 1/2016

Login to get access

Abstract

Background

Compromised bone stock and heavily impaired structural integrity after multiple endoprosthetic revision surgeries can lead to a comparable condition as encountered in musculoskeletal tumor surgery. Total femoral replacement (TFR) can restore femoral integrity and allow patients to resume ambulation. Even though several authors reported their results of TFR, so far many questions are still on debate: Which patients are at risk to experience low functional outcome? Do complications and clinical outcome after TFR depend on the indication for the surgery (e.g. periprosthetic fractures or aseptic loosening) or the age of the patients? The purpose of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients without malignant disease.

Methods

We conducted a retrospective chart review and functional investigation of patients treated with a TFR for non-oncologic conditions from 1995 to 2015 and a minimum follow-up of 2 years. Complications were recorded according to the Henderson-Classification; outcome was evaluated with established clinical scores. The indication for TFR was periprosthetic fracture (Group A, n = 11) or aseptic loosening (Group B, n = 7) with massive bone defect of the femur deemed unsuitable for conventional arthroplastic or biologic reconstruction.

Results

Eighteen patients matched the inclusion criteria and could be investigated clinically after a mean follow-up of 80 months (range: 28–132). Before TFA, all patients had previously undergone multiple operations (range: 1–8). The overall failure rate for any reason was 72% (n = 13/18), leading to a total of 37 surgical revisions with total exchange of TFR in 22% (n = 4/18). Most common failure mechanism was Type I (soft tissue), followed by Type IV (infection) and Type III (mechanical failure). According to Enneking’s functional evaluation method (MSTS-Score), the function ranged from 1 to 15 with a mean of 10 ± 4 out of 30.

Conclusion

TFR is a salvage procedure to restore mechanical integrity and regain functional ability after extensive femoral bone loss. Outcome of the patients in the present study did mainly depend on the age at reconstruction and not on the indication for TFR.
Literature
1.
go back to reference Lombardi Jr AV, Berend KR. The shattered femur: radical solution options. J Arthroplasty. 2006;21:107–11.CrossRefPubMed Lombardi Jr AV, Berend KR. The shattered femur: radical solution options. J Arthroplasty. 2006;21:107–11.CrossRefPubMed
2.
go back to reference Pennekamp PH, Wirtz DC, Durr HR. Proximal and total femur replacement. Oper Orthop Traumatol. 2012;24:215–26.CrossRefPubMed Pennekamp PH, Wirtz DC, Durr HR. Proximal and total femur replacement. Oper Orthop Traumatol. 2012;24:215–26.CrossRefPubMed
4.
go back to reference Kalra S, Abudu A, Murata H, Grimer RJ, Tillman RM, Carter SR. Total femur replacement: primary procedure for treatment of malignant tumours of the femur. Eur J Surg Oncol. 2010;36:378–83.CrossRefPubMed Kalra S, Abudu A, Murata H, Grimer RJ, Tillman RM, Carter SR. Total femur replacement: primary procedure for treatment of malignant tumours of the femur. Eur J Surg Oncol. 2010;36:378–83.CrossRefPubMed
5.
go back to reference Natarajan MV, Balasubramanian N, Jayasankar V, Sameer M. Endoprosthetic reconstruction using total femoral custom mega prosthesis in malignant bone tumours. Int Orthop. 2009;33:1359–63.CrossRefPubMedPubMedCentral Natarajan MV, Balasubramanian N, Jayasankar V, Sameer M. Endoprosthetic reconstruction using total femoral custom mega prosthesis in malignant bone tumours. Int Orthop. 2009;33:1359–63.CrossRefPubMedPubMedCentral
6.
go back to reference Nerubay J, Katznelson A, Tichler T, Rubinstein Z, Morag B, Bubis JJ. Total femoral replacement. Clin Orthop Relat Res. 1988;4:143–48. Nerubay J, Katznelson A, Tichler T, Rubinstein Z, Morag B, Bubis JJ. Total femoral replacement. Clin Orthop Relat Res. 1988;4:143–48.
7.
go back to reference Puri A, Gulia A, Chan WH. Functional and oncologic outcomes after excision of the total femur in primary bone tumors: Results with a low cost total femur prosthesis. Indian J Orthop. 2012;46:470–4.CrossRefPubMedPubMedCentral Puri A, Gulia A, Chan WH. Functional and oncologic outcomes after excision of the total femur in primary bone tumors: Results with a low cost total femur prosthesis. Indian J Orthop. 2012;46:470–4.CrossRefPubMedPubMedCentral
8.
go back to reference Ruggieri P, Bosco G, Pala E, Errani C, Mercuri M. Local recurrence, survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas. Clin Orthop Relat Res. 2010;468:2860–6.CrossRefPubMedPubMedCentral Ruggieri P, Bosco G, Pala E, Errani C, Mercuri M. Local recurrence, survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas. Clin Orthop Relat Res. 2010;468:2860–6.CrossRefPubMedPubMedCentral
9.
go back to reference Amanatullah DF, Trousdale RT, Hanssen AD, Lewallen DG, Taunton MJ. Non-oncologic total femoral arthroplasty: retrospective review. J Arthroplasty. 2014;29:2013–5.CrossRefPubMed Amanatullah DF, Trousdale RT, Hanssen AD, Lewallen DG, Taunton MJ. Non-oncologic total femoral arthroplasty: retrospective review. J Arthroplasty. 2014;29:2013–5.CrossRefPubMed
10.
go back to reference Berend KR, Lombardi AV, Jr., Mallory TH, Adams JB, Dodds KL. Total femoral arthroplasty for salvage of end-stage prosthetic disease. Clin Orthop Relat Res. 2004;2:162–70. Berend KR, Lombardi AV, Jr., Mallory TH, Adams JB, Dodds KL. Total femoral arthroplasty for salvage of end-stage prosthetic disease. Clin Orthop Relat Res. 2004;2:162–70.
11.
go back to reference Fountain JR, Dalby-Ball J, Carroll FA, Stockley I. The use of total femoral arthroplasty as a limb salvage procedure: the Sheffield experience. J Arthroplasty. 2007;22:663–9.CrossRefPubMed Fountain JR, Dalby-Ball J, Carroll FA, Stockley I. The use of total femoral arthroplasty as a limb salvage procedure: the Sheffield experience. J Arthroplasty. 2007;22:663–9.CrossRefPubMed
12.
go back to reference Friesecke C, Plutat J, Block A. Revision arthroplasty with use of a total femur prosthesis. J Bone Joint Surg Am. 2005;87:2693–701.PubMed Friesecke C, Plutat J, Block A. Revision arthroplasty with use of a total femur prosthesis. J Bone Joint Surg Am. 2005;87:2693–701.PubMed
13.
14.
go back to reference Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93:418–29.CrossRefPubMed Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93:418–29.CrossRefPubMed
15.
go back to reference Mazoochian F, Pietschmann MF, Hocke S, Fottner A, VS-P C, Jansson V. Hip dislocation following THA. Orthopade. 2007;36:935–8. 940, 942–933.CrossRefPubMed Mazoochian F, Pietschmann MF, Hocke S, Fottner A, VS-P C, Jansson V. Hip dislocation following THA. Orthopade. 2007;36:935–8. 940, 942–933.CrossRefPubMed
16.
go back to reference Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br. 2006;88:790–5.CrossRefPubMed Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br. 2006;88:790–5.CrossRefPubMed
17.
go back to reference Biau D, Faure F, Katsahian S, Jeanrot C, Tomeno B, Anract P. Survival of total knee replacement with a megaprosthesis after bone tumor resection. J Bone Joint Surg Am. 2006;88:1285–93.PubMed Biau D, Faure F, Katsahian S, Jeanrot C, Tomeno B, Anract P. Survival of total knee replacement with a megaprosthesis after bone tumor resection. J Bone Joint Surg Am. 2006;88:1285–93.PubMed
18.
go back to reference Guo W, Ji T, Yang R, Tang X, Yang Y. Endoprosthetic replacement for primary tumours around the knee: experience from Peking University. J Bone Joint Surg Br. 2008;90:1084–9.CrossRefPubMed Guo W, Ji T, Yang R, Tang X, Yang Y. Endoprosthetic replacement for primary tumours around the knee: experience from Peking University. J Bone Joint Surg Br. 2008;90:1084–9.CrossRefPubMed
19.
go back to reference Shehadeh A, Noveau J, Malawer M, Henshaw R. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop Relat Res. 2010;468:2885–95.CrossRefPubMedPubMedCentral Shehadeh A, Noveau J, Malawer M, Henshaw R. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop Relat Res. 2010;468:2885–95.CrossRefPubMedPubMedCentral
20.
go back to reference Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS. Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses. Clin Orthop Relat Res. 2006;450:52–9.CrossRefPubMed Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS. Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses. Clin Orthop Relat Res. 2006;450:52–9.CrossRefPubMed
21.
go back to reference Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res. 2006;450:164–71.CrossRefPubMed Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res. 2006;450:164–71.CrossRefPubMed
22.
go back to reference Healey JH, Morris CD, Athanasian EA, Boland PJ. Compress knee arthroplasty has 80% 10-year survivorship and novel forms of bone failure. Clin Orthop Relat Res. 2013;471:774–83.CrossRefPubMed Healey JH, Morris CD, Athanasian EA, Boland PJ. Compress knee arthroplasty has 80% 10-year survivorship and novel forms of bone failure. Clin Orthop Relat Res. 2013;471:774–83.CrossRefPubMed
23.
go back to reference Pala E, Henderson ER, Calabro T, Angelini A, Abati CN, Trovarelli G, Ruggieri P. Survival of current production tumor endoprostheses: complications, functional results, and a comparative statistical analysis. J Surg Oncol. 2013;108:403–8.CrossRefPubMed Pala E, Henderson ER, Calabro T, Angelini A, Abati CN, Trovarelli G, Ruggieri P. Survival of current production tumor endoprostheses: complications, functional results, and a comparative statistical analysis. J Surg Oncol. 2013;108:403–8.CrossRefPubMed
24.
go back to reference Gerdesmeyer L, Topfer A, Kircher J, Grundei H, Diehl P. The modular MML revision system in knee revision and tumor arthroplasty. Orthopade. 2006;35:975–81.CrossRefPubMed Gerdesmeyer L, Topfer A, Kircher J, Grundei H, Diehl P. The modular MML revision system in knee revision and tumor arthroplasty. Orthopade. 2006;35:975–81.CrossRefPubMed
25.
go back to reference Militz M, Buhren V. Replacement of infected knee and hip endoprostheses. Chirurg. 2010;81:310–20.CrossRefPubMed Militz M, Buhren V. Replacement of infected knee and hip endoprostheses. Chirurg. 2010;81:310–20.CrossRefPubMed
Metadata
Title
Short- to long-term follow-up of total femoral replacement in non-oncologic patients
Authors
Andreas Toepfer
Norbert Harrasser
Isabel Petzschner
Florian Pohlig
Ulrich Lenze
Ludger Gerdesmeyer
Dominik Pförringer
Marcel Toepfer
Marc Beirer
Moritz Crönlein
Ruediger von Eisenhart-Rothe
Heinz Mühlhofer
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2016
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-016-1355-6

Other articles of this Issue 1/2016

BMC Musculoskeletal Disorders 1/2016 Go to the issue